Ładuje się......
Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension
The efficacy and safety of azilsartan medoxomil (AZL‐M) were evaluated in African‐American patients with hypertension in a 6‐week, double‐blind, randomized, placebo‐controlled trial, for which the primary end point was change from baseline in 24‐hour mean systolic blood pressure (BP). There were 413...
Zapisane w:
| Wydane w: | J Clin Hypertens (Greenwich) |
|---|---|
| Główni autorzy: | , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley and Sons Inc.
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8031359/ https://ncbi.nlm.nih.gov/pubmed/28493376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12993 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|